Facile Entry to an Efficient and Practical Enantioselective Synthesis of A Polycyclic Cholesteryl Ester Transfer Protein Inhibitor
Zhengxu S. Han,Yibo Xu,Daniel R. Fandrick,Sonia Rodriguez,Zhibin Li,Bo Qu,Nina C. Gonnella,Sanjit Sanyal,Jonathan T. Reeves,Shengli Ma,Nelu Grinberg,Nizar Haddad,Dhileep Krishnamurthy,Jinhua J. Song,Nathan K. Yee,Waldemar Pfrengle,Markus Ostermeier,Juergen Schnaubelt,Zeno Leuter,Sonja Steigmiller,Juergen Daeubler,Emanuel Stehle,Lukas Neumann,Thomas Trieselmann,Patrick Tielmann,Annette Buba,Rainer Hamm,Gunter Koch,Svenja Renner,Juan R. Dehli,Florian Schmelcher,Christian Stange,Juergen Mack,Rainer Soyka,Chris H. Senanayake
DOI: https://doi.org/10.1021/ol501833g
IF: 5.2
2014-01-01
Organic Letters
Abstract:An efficient enantioselective synthesis of the chiral polycyclic cholesteryl ester transfer protein (CETP) inhibitor 1 has been developed. The synthesis was rendered practical for large scale via the development of a modified Hantzsch-type reaction to prepare the sterically hindered pyridine ring, enantioselective hydrogenation of hindered ketone 6 utilizing novel BIBOP-amino-pyridine derived Ru complex, efficient ICl promoted lactone formation, and a BF3 mediated hydrogenation process for diastereoselective lactol reduction. This efficient route was successfully scaled to produce multikilogram quantities of challenging CETP drug candidate 1.